Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Prognostic Value of TTM with TTM Distribution and Ball Score in Relapsed/Refractory Ibrutinib Treated B-CLL - in the Real-World Setting

Ozren Jaksic, MDPhD, Marija Ivic, MD, Rajko Kusec, MD PhD, Zdravko Mitrovic, MD PhD, Mario Pirsic, MD, Branimir Jaksic, MD PhD, David Cicic, MD, Vlatko Pejsa, MD PhD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-143030

Published: 2020

Journal Articles

Different Pattern of Expression of CD52, CD20 and CXCR-4 in Peripheral Blood, Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia (B-CLL),

Ozren Jaksic, MD, PhD, Branimir Gizdic, Tajana Stoos Veic, MD, Vlatka Pandzic Jaksic, MD, PhD, Rajko Kusec, MD, PhD, Vlatko Pejsa, MD, PhD, Branimir Jaksic, MD, PhD

Blood (2011) 118 (21): 3877.

https://doi.org/10.1182/blood.V118.21.3877.3877

Published: 2011

Journal Articles

Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Ozren Jaksic, MD, PhD, Branimir Gizdic, Tajana Stoos Veic, MD, Vlatka Pandzic Jaksic, MD, PhD, Rajko Kusec, MD, PhD, Vlatko Pejsa, MD, PhD, Branimir Jaksic, MD, PhD

Blood (2010) 116 (21): 3607.

https://doi.org/10.1182/blood.V116.21.3607.3607

Published: 2010

Journal Articles

Differences between Peripheral Blood, Lymph Nodes and Bone Marrow in Expression of Integrins, ICAMs, CD38 and CD31 Correlate with Clinical Characteristics in B-CLL.

Branimir Jaksic, MD, PhD, Ozren Jaksic, MD, MSc, Mirjana M. Kardum-Paro, MSc, Ika Kardum-Skelin, MD, MSc

Blood (2005) 106 (11): 4981.

https://doi.org/10.1182/blood.V106.11.4981.4981

Published: 2005

Journal Articles

Preliminary Safety and Efficacy Report of a Randomized Trial of Alemtuzumab vs Chlorambucil as Front-Line Therapy in 297 Patients with Progressive B-Cell Chronic Lymphocytic Leukemia.

Peter Hillmen, MB ChB, PhD, Aleksander B. Skotnicki, MD, PhD, Tadeusz Robak, MD, PhD, Jiri Mayer, MD, PhD, Branimir Jaksic, MD, PhD, Vojo Vukovic, MD, PhD, Steven Weitman, MD, PhD

Blood (2004) 104 (11): 2505.

https://doi.org/10.1182/blood.V104.11.2505.2505

Published: 2004

NARROW

Prognostic Value of TTM with TTM Distribution and Ball Score in Relapsed/Refractory Ibrutinib Treated B-CLL - in the Real-World Setting

Different Pattern of Expression of CD52, CD20 and CXCR-4 in Peripheral Blood, Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia (B-CLL),

Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Differences between Peripheral Blood, Lymph Nodes and Bone Marrow in Expression of Integrins, ICAMs, CD38 and CD31 Correlate with Clinical Characteristics in B-CLL.

Preliminary Safety and Efficacy Report of a Randomized Trial of Alemtuzumab vs Chlorambucil as Front-Line Therapy in 297 Patients with Progressive B-Cell Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Prognostic Value of TTM with TTM Distribution and Ball Score in Relapsed/Refractory Ibrutinib Treated B-CLL - in the Real-World Setting

Different Pattern of Expression of CD52, CD20 and CXCR-4 in Peripheral Blood, Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia (B-CLL),

Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Differences between Peripheral Blood, Lymph Nodes and Bone Marrow in Expression of Integrins, ICAMs, CD38 and CD31 Correlate with Clinical Characteristics in B-CLL.

Preliminary Safety and Efficacy Report of a Randomized Trial of Alemtuzumab vs Chlorambucil as Front-Line Therapy in 297 Patients with Progressive B-Cell Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only